Contura Orthopaedics

Contura Orthopaedics is a medical technology company specializing in the development and commercialization of innovative hydrogel-based therapies for musculoskeletal conditions. The company's flagship product, Arthrosamid, is a non-biodegradable polyacrylamide hydrogel (iPAAG) injected into the intra-articular space to provide long-lasting pain relief for patients with knee osteoarthritis. Unlike traditional viscosupplements, Arthrosamid integrates into the synovial membrane, offering a unique mechanism of action that improves joint function and reduces pain without being absorbed by the body. Contura Orthopaedics operates as a dedicated division of Contura International, leveraging over 20 years of experience in hydrogel technology originally developed for other medical applications. The company is currently focused on expanding the clinical evidence and global market presence of its single-injection treatment.